CUSIP: 74348A541
Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / HGH YLD INT RATE
-
Total 13F shares
-
1,104,452
-
Share change
-
-50,125
-
Total reported value
-
$71,172,283
-
Price per share
-
$64.40
-
Number of holders
-
47
-
Value change
-
-$3,236,073
-
Number of buys
-
22
-
Number of sells
-
20
Security key
74348A541
Report period
Q4 2025
Institutions
47
Top holders
10
Reporting periods
Holder history for CUSIP 74348A541
Recent filing periods:
Top shareholders of HYHG - PROSHARES TR - HGH YLD INT RATE (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of PROSHARES TR - HGH YLD INT RATE (HYHG) as of Q4 2025
As of 31 Dec 2025,
PROSHARES TR - HGH YLD INT RATE (HYHG) was held by
47 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,104,452 shares.
The largest 10 holders included
MORGAN STANLEY, WELLS FARGO & COMPANY/MN, Sound Income Strategies, LLC, Larry Mathis Financial Planning, LLC, LPL Financial LLC, MML INVESTORS SERVICES, LLC, ENVESTNET ASSET MANAGEMENT INC, Alta Fundamental Advisers LLC, JANE STREET GROUP, LLC, and Howard Capital Management Inc..
This page lists
47
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q4 2025 vs Q3 2025 Across Filers
| Investor |
Q3 2025 Shares |
Q4 2025 Shares |
Share Diff |
Share Chg % |
Q3 2025 Value $ |
Q4 2025 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.